Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Fibronectin

Fibronectin

Brief Information

Name:Fibronectin
Target Synonym:Epididymis Secretory Sperm Binding Protein,Migration-Stimulating Factor,CIG,GFND2,SMDCF,ED-B,FINC,GFND,LETS,FNZ,MSF,Fibronectins,FN,FN1,Fibronectin,Fibronectin 1,Cold-Insoluble Globulin
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
GMP-FINH18 Human GMP Recombinant Human Fibronectin fragment
GMP-FINH18-structure
GMP-FINH18-sds
GMP-FINH18-hplc
FIN-H5116 Human Recombinant Fibronectin fragment, premium grade
FIN-H5116-structure
FIN-H5116-sds
FIN-H5116-hplc
ACRO Quality

Part of Bioactivity data

FIN-H5116-MALS-HPLC
 Fibronectin ELISA

Immobilized Recombinant Fibronectin fragment, premium grade (Cat. No. FIN-H5116) at 5 μg/mL (100 μL/well) can bind Biotinylated Human ITGA4&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82W1) with a linear range of 0.002-0.078 μg/mL (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Ocriplasmin A-01016; THR-409 Approved Thrombogenics Jetrea, Jejetrea United States Vitreomacular Adhesion Thrombogenics Inc 2012-10-17 Vitreous Detachment; Arterial Occlusive Diseases; Disease Progression; Stroke; Retinal Diseases; Diabetic macular oedema; Uveitis; Vitreomacular Adhesion; Eye Diseases; Venous Thrombosis; Macular Degeneration; Diabetic Retinopathy; Retinal Vein Occlusion Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Onfekafusp alfa Phase 3 Clinical Philogen Spa Solid tumours; Glioblastoma; Sarcoma; Breast Neoplasms; Genital Neoplasms, Female; Colorectal Neoplasms; Glioma; Lung Neoplasms; Melanoma Details
Darleukin/fibromun L19-IL-2/ L19-TNF-α Phase 3 Clinical Philogen Spa Carcinoma, Merkel Cell; Carcinoma, Basal Cell; Carcinoma, Skin Appendage; Keratoacanthoma; Basal Cell Nevus Syndrome; Carcinoma, Squamous Cell; Lymphoma, T-Cell, Cutaneous; Melanoma; Sarcoma, Kaposi Details
Bifikafusp alfa L19-IL-2 Phase 3 Clinical Philogen Spa Solid tumours; Adenomatous Polyposis Coli; Pancreatic Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung Details
Radretumab L19-I131; L19-SIP; I-L19-SIP; I-131-L19-SIP; 131I-L19-SIP; L19-131-I; 131I-radretumab; 131I-L19SIP; L19-131I Phase 2 Clinical Philogen Spa Hematologic Neoplasms; Hodgkin Disease; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung Details
PYX-201 PYX-201 Phase 2 Clinical Pfizer Inc Solid tumours Details
F8-IL10 F8-IL10; PF-06687234 Phase 2 Clinical Philogen Spa Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Colitis, Ulcerative Details
177Lu-B5-IgG4 177-Lu-B5-IgG4 Phase 1 Clinical Affiliated Hospital of Jiangnan University Solid tumours Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message